Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D-2 receptor antagonist L-741,626

被引:54
作者
Bowery, BJ [1 ]
Razzaque, Z [1 ]
Emms, F [1 ]
Patel, S [1 ]
Freedman, S [1 ]
Bristow, L [1 ]
Kulagowski, J [1 ]
Seabrook, GR [1 ]
机构
[1] MERCK SHARP & DOHME LTD,NEUROSCI RES CTR,HARLOW CM20 2QR,ESSEX,ENGLAND
关键词
D-2 dopamine receptor; schizophrenia; quinpirole; dopamine; ventral tegmental area; substantia nigra; electrophysiology;
D O I
10.1111/j.1476-5381.1996.tb16063.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The ability of PD 128907 to activate dopamine receptors in the ventral tegmental area, substantia nigra pars compacta, and striatum was investigated by use of in vitro electrophysiological recodring and fast cyclic voltammetry. The affinity of a novel D-2 selective antagonist L-741,626 for recectors activated by this agonist ws measured to determine if its effects were mediated by D-2 or D-3 receptors. 2 The active (+) enantiomer of PD 128907 bound with high affinity and selectivity to rat D-3 dopamine receptors. The K-i values for (+)-PD 128907 were 620 nM at D-2, 1 nM at D-3 and 720 nM at D-4 receptors. 3 (+)-PD 128907 inhibited cell firing in both the ventral tegmental area and substantia nigra pars compacta with EC(50) values of 33 nM (pEC(50)=7.48+/-0.10, n=10) and 38 nM (pEC(50)=7.42+/-0.15, n=5), respectively. No effects of (+)-PD 128907 (100 nM) were observed on glutamate or GABA-mediated synaptic potentials elicited by focal bipolar stimulation. 4 L-741,626 antagonized these efects of (+)-PD 128907 in a concentration-dependent and surmountable manner with an affinity, determined from Schild analysis, of 20nM (pK(B)=7.71+/-0.14) in the ventral tegmental area and 11 nM (pK(B)=7.95+/-0.18) in the substantia nigra pars compacta. 5 (+)-PD128907 also inhibited dopamine release in the caudata-putamen with an EC(50) of 66 nM (n=5). The affinity of L-741,626 for these nerve terminal autoreceptors (pK(B)=7.71+/-0.06; =20 nM) was identical to that observed on midbrain dopamine neurons. 6 These data demonstrate that the D-3 receptor ligand (+)-PD 128907 is a potent agonis on rat midbrain dopamine neurones. However, its lack of reginal selectivity, and the high affinity of the selective D-2 receptor antagonist L-741,626 for receptors activated by (+)-PD 128907, was more consistent with an action on D-2 autoreceptors rather than upon a D-3 dopamine receptor subtype.
引用
收藏
页码:1491 / 1497
页数:7
相关论文
共 39 条
  • [1] ARETHA CW, 1995, J PHARMACOL EXP THER, V274, P609
  • [2] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
    ARUNLAKSHANA, O
    SCHILD, HO
    [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01): : 48 - 58
  • [3] LOCALIZATION OF DOPAMINE-D3 RECEPTOR MESSENGER-RNA IN THE RAT-BRAIN USING INSITU HYBRIDIZATION HISTOCHEMISTRY - COMPARISON WITH DOPAMINE-D2 RECEPTOR MESSENGER-RNA
    BOUTHENET, ML
    SOUIL, E
    MARTRES, MP
    SOKOLOFF, P
    GIROS, B
    SCHWARTZ, JC
    [J]. BRAIN RESEARCH, 1991, 564 (02) : 203 - 219
  • [4] COMPARISON BETWEEN THE PHARMACOLOGY OF DOPAMINE-RECEPTORS MEDIATING THE INHIBITION OF CELL FIRING IN RAT-BRAIN SLICES THROUGH THE SUBSTANTIA-NIGRA PARS COMPACTA AND VENTRAL TEGMENTAL AREA
    BOWERY, B
    ROTHWELL, LA
    SEABROOK, GR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (03) : 873 - 880
  • [5] BRISTOW LJ, 1996, IN PRESS NEUROPHARMA
  • [6] APPLICATION OF FAST CYCLIC VOLTAMMETRY TO MEASUREMENT OF ELECTRICALLY EVOKED DOPAMINE OVERFLOW FROM BRAIN-SLICES INVITRO
    BULL, DR
    PALIJ, P
    SHEEHAN, MJ
    MILLAR, J
    STAMFORD, JA
    KRUK, ZL
    HUMPHREY, PPA
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 1990, 32 (01) : 37 - 44
  • [7] CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA
    BUNZOW, JR
    VANTOL, HHM
    GRANDY, DK
    ALBERT, P
    SALON, J
    CHRISTIE, MJ
    MACHIDA, CA
    NEVE, KA
    CIVELLI, O
    [J]. NATURE, 1988, 336 (6201) : 783 - 787
  • [8] LACK OF DISCRIMINATION BY AGONISTS FOR D-2 AND D-3 DOPAMINE-RECEPTORS
    BURRIS, KD
    PACHECO, MA
    FILTZ, TM
    KUNG, MP
    KUNG, HF
    MOLINOFF, PB
    [J]. NEUROPSYCHOPHARMACOLOGY, 1995, 12 (04) : 335 - 345
  • [9] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [10] CHIO CL, 1994, MOL PHARMACOL, V45, P51